Page last updated: 2024-10-21

sk&f-38393 and Acute Confusional Senile Dementia

sk&f-38393 has been researched along with Acute Confusional Senile Dementia in 2 studies

2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine: A selective D1 dopamine receptor agonist used primarily as a research tool.
1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol : A benzazepine that is 2,3,4,5-tetrahydro-3-benzazepine bearing a phenyl substituent at position 1 and two hydroxy substituents at positions 7 and 8.
SKF 38393 : A racemate comprising equimolar amounts of (R)- and (S)-SKF 38393

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yuan Xiang, P1
Janc, O1
Grochowska, KM1
Kreutz, MR1
Reymann, KG1
Lumbreras, M1
Baamonde, C1
Martínez-Cué, C1
Lubec, G1
Cairns, N1
Sallés, J1
Dierssen, M1
Flórez, J1

Other Studies

2 other studies available for sk&f-38393 and Acute Confusional Senile Dementia

ArticleYear
Dopamine agonists rescue Aβ-induced LTP impairment by Src-family tyrosine kinases.
    Neurobiology of aging, 2016, Volume: 40

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Alzheimer Disease; Amyloid beta-Peptides

2016
Brain G protein-dependent signaling pathways in Down syndrome and Alzheimer's disease.
    Amino acids, 2006, Volume: 31, Issue:4

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adenylyl Cyclases; Aged; Alzheimer Disea

2006